Desferal

Desferal is a brand name of deferoxamine, approved by the FDA in the following formulation(s):

DESFERAL (deferoxamine mesylate - injectable; injection)

• 
  Manufacturer: NOVARTIS
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 500MG/VIAL ^[RLD][AP]


• 
  Manufacturer: NOVARTIS
  
  Approval date: May 25, 2000
  
  Strength(s): 2GM/VIAL ^[RLD][AP]

Has a generic version of Desferal been approved?

Yes. The following products are equivalent to Desferal:

deferoxamine mesylate injectable; injection

• 
  Manufacturer: APP PHARMS
  
  Approval date: September 15, 2009
  
  Strength(s): 2GM/VIAL ^[AP], 500MG/VIAL ^[AP]


• 
  Manufacturer: BEDFORD
  
  Approval date: May 30, 2007
  
  Strength(s): 2GM/VIAL ^[AP], 500MG/VIAL ^[AP]


• 
  Manufacturer: HOSPIRA
  
  Approval date: March 17, 2004
  
  Strength(s): 2GM/VIAL ^[AP], 500MG/VIAL ^[AP]


• 
  Manufacturer: WATSON LABS
  
  Approval date: March 31, 2006
  
  Strength(s): 2GM/VIAL ^[AP], 500MG/VIAL ^[AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Desferal. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Desferal.

See also...

• Desferal Consumer Information (Wolters Kluwer)
• Desferal Consumer Information (Cerner Multum)
• Desferal Advanced Consumer Information (Micromedex)
• Desferal AHFS DI Monographs (ASHP)
• Deferoxamine Consumer Information (Wolters Kluwer)
• Deferoxamine Consumer Information (Cerner Multum)
• Deferoxamine Injection Advanced Consumer Information (Micromedex)
• Deferoxamine Mesylate AHFS DI Monographs (ASHP)